|Mr. Scott Raymond Ward MS, B.Sc.||Chairman, Chief Exec. Officer and Pres||548.46k||N/A||58|
|Mr. Laurence L. Betterley||Chief Financial Officer||493.8k||N/A||63|
|Mr. Kevin J. Kenny||Chief Operating Officer||651.3k||N/A||52|
|Mr. Paul A. Koehn||Sr. VP of Manufacturing, Operations and Quality||426.21k||N/A||54|
|Mr. Jack E. Nielsen||Sr. Director of Corp. Communications & IR||N/A||N/A||N/A|
Cardiovascular Systems, Inc., a medical technology company, develops, manufactures, and markets devices to treat vascular diseases in the United States. It offers peripheral arterial disease products, including Diamondback 360 Peripheral Orbital Atherectomy System (OAS), Stealth 360° Peripheral OAS, Diamondback 360 60cm Peripheral OAS, Diamondback 360 Low Profile Peripheral OAS, Diamondback 360 1.50 Peripheral OAS, and Diamondback 360 2.00 Peripheral OAS, which are catheter-based platforms for treating a range of plaque types, such as calcified plaque, in leg arteries both above and below the knee and address many of the limitations associated with other surgical, catheter, and pharmacological treatment alternatives, as well as Diamondback 360 Coronary OAS, an atherectomy device for the treatment of calcified coronary arteries. The company sells its products directly to hospitals or office-based labs. Cardiovascular Systems, Inc. was founded in 1989 and is headquartered in St. Paul, Minnesota.
Cardiovascular Systems, Inc.’s ISS Governance QualityScore as of May 1, 2017 is 5. The pillar scores are Audit: 2; Board: 3; Shareholder Rights: 6; Compensation: 6.